As Chief Financial Officer, Kelly is a key advisor to the CEO and Executive Team on strategic and financial matters, working closely with LifeLabs’ Board of Directors and audit committee. Kelly plays a critical role in increasing LifeLabs’ ability to further leverage its core lab services capabilities while fueling innovation by capitalizing on growth opportunities to continue to diversify its service offerings.
Acting as a change agent, Kelly will build LifeLabs’ commercial acumen by developing sound financial plans and simplifying operating policies and procedures. Her mandate is to evolve the financial operations beyond debits and credits by utilizing financial and customer data to drive a culture of continuous improvement within the organization.
Named “Best Executive” in 2022 by The Globe and Mail’s Report on Business Magazine, Kelly has over 25 years of organizational and C-Suite leadership experience, with an emphasis on the pharmaceutical sector and brings a broad and unique background in both finance and logistics across multiple sectors. Kelly has a consistent track record of developing winning strategies to realign resources, deliver operational excellence and improve profit margins.
Prior to joining LifeLabs, Kelly held several Chief Financial Officer positions, most recently at Wolseley Canada Inc. Kelly is a chartered professional accountant and received a Bachelor of Commerce degree from the University of Toronto.